Ibuprofen Linked to Reduced Alzheimer's Risk

Other painkillers show some benefit, but more research needed, study says

By Amanda Gardner
HealthDay Reporter

Related Encyclopedia • Abdominoplasty • Acidophilus • Acoustic Neurinoma • Alzheimer's Disease More... Related Healthscout Videos Controlling Incontinence Critical Nutrition Preventing Heart Disease the Easy Way Lifestyle Changes for Heart Disease Prevention and Treatment More... Related Animations • Alzheimer's Disease Video Animation • Erectile Dysfunction • What is a Heart Attack? More... Related Drug Information • Actonel • Adderal XR • Concerta • Coumadin More... Related News Articles • Get Healthy: Your Middle-Aged Heart Will Thank You • Mom's Vitamin D Levels Affect Baby's Dental Health • Anxiety, Shyness May Be Long-Lasting Traits • Gender Plays Role in Kidney Transplant Outcomes More...

MONDAY, May 5 (HealthDay News) -- People who use the painkiller ibuprofen regularly for five years may be less likely to develop Alzheimer's disease as they age, a new study suggests.

And more generally, people using the class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs) may have a decreased risk for Alzheimer's as well, although the link here is not as clear-cut as it is for ibuprofen.

Text Continues Below

---

But the findings don't put to rest a debate that has long simmered about the role of NSAIDs in the prevention or treatment of Alzheimer's, given the gastrointestinal side effects associated with long-term use of this class of painkillers.

"This discussion has been going on for a while," said William Thies, vice president of medical and scientific relations for the Alzheimer's Association. "This trial is big enough and the results are good enough that it may reopen the debate -- that we should do a prevention study with these medications."

But at this point, the conclusions aren't firm enough to start taking ibuprofen or any other NSAID to help ward off dementia, he said.

"Probably people shouldn't be taking these medications just to prevent Alzheimer's. The effect is too uncertain and the side effects are pretty well known," Thies said. "For those people who won't listen to this advice, they should be really careful to fill in their physician so he can track it with other medications."

Dr. Steven Vlad, lead author of the study and a fellow in rheumatology at Boston University School of Medicine, agreed, saying: "The big issue is that ibuprofen looks like it prevents Alzheimer's but all these drugs have well-known side effects and significant side effects, so the risk-benefit ratio is not clear at this point. Patients shouldn't go on ibuprofen to prevent Alzheimer's."

The findings are published in the May 6 issue of Neurology.

While so-called epidemiological studies have indicated some dementia prevention benefit with NSAIDs and ibuprofen, treatment trials have shown no benefits.

Page:  1 | 2 | 3 | Next >>